National Health (Pharmaceutical Benefits)
(Pharmacist Substitution of Medicines without
Prescription during Shortages) Amendment (No. 3) Determination 2023
I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.
Dated 1 May 2023
Nikolai Tsyganov
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name...............................................1
2 Commencement.........................................1
3 Authority.............................................1
4 Schedules.............................................1
Schedule 1—Amendments 2
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021
(2) This instrument may also be cited as PB 41 of 2023.
2 Commencement
Commencement information |
| |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 May 2023 | 1 May 2023 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument.
Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 89A(3) of the National Health Act 1953.
4 Schedules
Schedule 1—Amendments
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of
Medicines without Prescription during Shortages) Determination 2021
1 Subsection 5(8), after item 42 dealing with Phenoxymethylpenicillin
Insert:
Listed drug: Cefaclor Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL Manner of administration: Oral Brand: Ceclor | Listed drug: Cefaclor Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL Manner of administration: Oral Brand: Any of the following a) Ceclor b) Keflor c) APO-Cefaclor d) Aclor 250 | |
44 | Listed drug: Cefaclor Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL Manner of administration: Oral Brand: Keflor | Listed drug: Cefaclor Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL Manner of administration: Oral Brand: Any of the following a) Ceclor b) Keflor c) APO-Cefaclor d) Aclor 250 |
45 | Listed drug: Cefaclor Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL Manner of administration: Oral Brand: Ceclor | Listed drug: Cefaclor Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL Brand: Any of the following: a) Ceclor b) Keflor c) Aclor 125 |
Listed drug: Cefaclor Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL Manner of administration: Oral Brand: Keflor | Listed drug: Cefaclor Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL Manner of administration: Oral Brand: Any of the following: a) Ceclor b) Keflor c) Aclor 125 |